Article Details
Retrieved on: 2021-02-26 22:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here